Abstract
No public abstract is available from the verified source records.
Clayton Kramm, Warren Lockette
Abstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
europepmc
Confidence 96%
unpaywall
Confidence 95%
doaj
Confidence 92%
datacite
Confidence 0%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Perioperative hypertensive emergencies
10.1007/s11906-014-0448-6 · 2014
Preoperative hypertension
10.1007/s40140-018-0248-7 · 2018
Hypertension. Preoperative assessment and perioperative management
1995
Blood pressure targets in perioperative care: provisional considerations based on a comprehensive literature review
10.1161/hypertensionaha.118.11688 · 2018
Studies of anaesthesia in relation to hypertension. I. Cardiovascular responses of treated and untreated patients
10.1093/bja/43.2.122 · 1971
Association of preanesthesia hypertension with adverse outcomes
10.1053/j.jvca.2010.06.022 · 2010
New advances in endocrine hypertension: from genes to biomarkers
10.1016/j.kint.2022.12.021 · 2023
Improvement of hypertension control and left-ventricular function after cure of primary hyperparathyroidism
10.3389/fendo.2023.1163877 · 2023
Parathyroidectomy decreases systolic and diastolic blood pressure in hypertensive patients with primary hyperparathyroidism
10.1016/j.surg.2009.09.024 · 2009
Hypertension in thyroid disorders
10.1016/s0889-8529(18)30103-8 · 1994
Pheochromocytoma as an endocrine emergency
10.1023/a:1022981801344 · 2003
Risk factors for hemodynamic instability during surgery for pheochromocytoma
10.1210/jc.2009-1051 · 2010
Current concepts of pheochromocytoma
10.1016/j.ijsu.2014.04.001 · 2014
Perioperative management of pheochromocytomas and sympathetic paragangliomas
10.1210/jendso/bvac004 · 2022
Pheochromocytoma/paraganglioma: review of perioperative management of blood pressure and update on genetic mutations associated with pheochromocytoma
10.1111/jch.12084 · 2013
Acute hypertensive crisis secondary to pheochromocytoma during elective cosmetic surgery
10.1097/prs.0000000000000784 · 2015
Pathophysiology and diagnosis of disorders of the adrenal medulla: focus on pheochromocytoma
10.1002/j.2040-4603.2014.tb00559.x · 2014
Adrenal pheochromocytoma remains a frequently overlooked diagnosis
10.1016/s0002-9610(00)00296-8 · 2000
Mortality associated with phaeochromocytoma
10.1055/s-0032-1331217 · 2013
Cardiovascular manifestations of pheochromocytoma
10.1097/hjh.0b013e32834a4ce9 · 2011
Life-threatening events in patients with pheochromocytoma
10.1530/eje-15-0483 · 2015
The management of primary aldosteronism: case detection, diagnosis, and treatment: an endocrine society clinical practice guideline
10.1210/jc.2015-4061 · 2016
Is laparoscopic adrenalectomy indicated for pheochromocytomas?
10.1016/s0039-6060(96)80058-4 · 1996
Surgical approach to patients with pheochromocytoma
10.21037/gs.2019.10.20 · 2020
Is the laparoscopic adrenalectomy for pheochromocytoma the best treatment?
10.1016/j.surg.2006.10.012 · 2007
Laparoscopic adrenalectomy for adrenal tumors with endocrine activity: perioperative management pathways for reduced complications and improved outcomes
10.1111/iju.15218 · 2023
Impact of dedicated multidisciplinary service on patient selection and outcomes for surgical treatment of primary aldosteronism
10.1016/j.surg.2022.08.010 · 2022
Surgical approach to endocrine hypertension in patients with adrenal disorders
10.1016/j.ecl.2019.08.014 · 2019
Pheochromocytoma and paraganglioma: an Endocrine Society Clinical Practice guideline
10.1210/jc.2014-1498 · 2014
Perioperative management of pheochromocytoma
10.1053/j.jvca.2017.02.023 · 2017
Intraoperative blood pressure. What patterns identify patients at risk for postoperative complications?
10.1097/00000658-199011000-00003 · 1990
2014 ESC/ESA guidelines on non-cardiac surgery: cardiovascular assessment and management
10.1093/eurheartj/ehu285 · 2014
The burden of perioperative hypertension/hypotension: a systematic review
2022
Association between intraoperative hypotension and hypertension and 30-day postoperative mortality in noncardiac surgery
10.1097/aln.0000000000000756 · 2015
Perioperative blood pressure management
10.1097/aln.0000000000003610 · 2021
Comparison of intraoperative arterial blood pressure lability during general anaesthesia in masked, uncontrolled hypertensive and adequately controlled hypertensive patients: a prospective observational study
10.5114/ait.2022.123143 · 2022
Preoperative α-blockade versus no blockade for pheochromocytoma–paraganglioma patients undergoing surgery: a systematic review and updated meta-analysis
10.1097/js9.0000000000000390 · 2023
Chromaffin cells of the adrenal medulla: physiology, pharmacology, and disease
10.1002/j.2040-4603.2019.tb00098.x · 2019
Overview of the 2022 WHO classification of paragangliomas and pheochromocytomas
10.1007/s12022-022-09704-6 · 2022
The molecular classification of pheochromocytomas and paragangliomas: discovering the genomic and immune landscape of metastatic disease
10.1007/s12022-024-09830-3 · 2024
Hypertensive urgencies and emergencies: prevalence and clinical presentation
10.1161/01.hyp.27.1.144 · doi-reference
False-positive results of adrenal venous sampling due to mild autonomous cortisol secretion in a patient with primary aldosteronism: a case report with review of literature
10.1507/endocrj.ej25-0312 · doi-reference
A unified cause for adrenal Cushing's syndrome
10.1126/science.1254901 · doi-reference
Molecular genetic and genomic alterations in Cushing’s syndrome and primary aldosteronism
10.3389/fendo.2021.632543 · doi-reference
The entity of Connshing syndrome: primary aldosteronism with autonomous cortisol secretion
10.3390/diagnostics12112772 · doi-reference
European Society of Endocrinology clinical practice guidelines on the management of adrenal incidentalomas, in collaboration with the European Network for the Study of Adrenal Tumors
10.1093/ejendo/lvad066 · doi-reference
Adrenalectomy improves blood pressure and metabolic control in patients with possible autonomous cortisol secretion: results of a RCT
10.3389/fendo.2022.898084 · doi-reference
Therapy of Endocrine Disease: improvement of cardiovascular risk factors after adrenalectomy in patients with adrenal tumors and subclinical Cushing's syndrome: a systematic review and meta-analysis
10.1530/eje-16-0465 · doi-reference
Cardiovascular and metabolic risk factors in patients with subclinical Cushing
10.1007/s12020-020-02297-2 · doi-reference
Comorbidities in mild autonomous cortisol secretion and the effect of treatment: systematic review and meta-analysis
10.1093/ejendo/lvad134 · doi-reference
Cardiovascular events and mortality in patients with adrenal incidentalomas that are either non-secreting or associated with intermediate phenotype or subclinical Cushing's syndrome: a 15-year retrospective study
10.1016/s2213-8587(13)70211-0 · doi-reference
Natural history of adrenal incidentalomas with and without mild autonomous cortisol excess: a systematic review and meta-analysis
10.7326/m18-3630 · doi-reference
Mild autonomous cortisol secretion: pathophysiology, comorbidities and management approaches
10.1038/s41574-024-00984-y · doi-reference
Glucocorticoid withdrawal syndrome following treatment of endogenous Cushing syndrome
10.1007/s11102-022-01218-y · doi-reference
Diagnostic utility of gallium-68-somatostatin receptor PET/CT in ectopic ACTH-secreting tumors: a systematic literature review and single-center clinical experience
10.1007/s11102-019-00972-w · doi-reference
The clinical impact of [68 Ga]-DOTATATE PET/CT for the diagnosis and management of ectopic adrenocorticotropic hormone - secreting tumors
10.1111/cen.14008 · doi-reference
Consensus on diagnosis and management of Cushing's disease: a guideline update
10.1016/s2213-8587(21)00235-7 · doi-reference
The diagnosis of Cushing’s syndrome: an Endocrine Society clinical practice guideline
10.1210/jc.2008-0125 · doi-reference
Genetics of Cushing’s syndrome
10.1016/j.ecl.2018.02.007 · doi-reference
Perioperative management of a patient with Cushing disease
10.1210/jendso/bvac010 · doi-reference
Acute and life-threatening complications in Cushing syndrome: prevalence, predictors, and mortality
10.1210/clinem/dgab058 · doi-reference
Long-term outcome of primary bilateral macronodular adrenocortical hyperplasia after unilateral adrenalectomy
10.1210/jc.2018-02204 · doi-reference
Treatment of Cushing's syndrome: an Endocrine Society clinical practice guideline
10.1210/jc.2015-1818 · doi-reference
The pathophysiology and treatment of hypertension in patients with Cushing's syndrome
10.3389/fendo.2019.00321 · doi-reference
Association of hypertension and hypokalemia with Cushing's syndrome caused by ectopic ACTH secretion: a series of 58 cases
10.1111/j.1749-6632.2002.tb04419.x · doi-reference
Metabolic and cardiovascular outcomes in patients with Cushing's syndrome of different aetiologies during active disease and 1 year after remission
10.1111/j.1365-2265.2011.04055.x · doi-reference
High cardiovascular risk in patients with Cushing's syndrome according to 1999 WHO/ISH guidelines
10.1111/j.1365-2265.2004.02168.x · doi-reference
Cardiovascular health and mortality in Cushing’s disease
10.1007/s11102-022-01258-4 · doi-reference
Long-term morbidity and mortality in patients with Cushing's syndrome
10.1111/jne.13113 · doi-reference
Complications of Cushing's syndrome: state of the art
10.1016/s2213-8587(16)00086-3 · doi-reference
Diagnosis and management of hypertension in patients with Cushing's syndrome: a position statement and consensus of the Working Group on Endocrine Hypertension of the European Society of Hypertension
10.1097/hjh.0000000000003252 · doi-reference
Altered circadian blood pressure rhythm in patients with Cushing's syndrome
10.1161/01.hyp.12.1.11 · doi-reference
The hypertension of Cushing's syndrome: controversies in the pathophysiology and focus on cardiovascular complications
10.1097/hjh.0000000000000415 · doi-reference
Global Cushing's disease epidemiology: a systematic review and meta-analysis of observational studies
10.1007/s40618-022-01754-1 · doi-reference
Cushing's syndrome
10.1016/s0140-6736(23)01961-x · doi-reference
Cushing syndrome: a review
10.1001/jama.2023.11305 · doi-reference
The basophil adenomas of the pituitary body and their clinical manifestations (pituitary basophilism)
10.3171/jns.1964.21.4.0318 · doi-reference
Renal damage in primary aldosteronism: a systematic review and meta-analysis
10.1097/hjh.0000000000002216 · doi-reference
Cardiometabolic outcomes and mortality in medically treated primary aldosteronism: a retrospective cohort study
10.1016/s2213-8587(17)30367-4 · doi-reference
Mineralocorticoid receptor antagonists for primary aldosteronism-appropriate or not?
10.1093/ejendo/lvad020 · doi-reference